ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag chronic pain evolution genetics genomics

The Human Genome
Arielle Emmett | Jul 23, 2000 | 10+ min read
Life sciences took center stage virtually around the world June 26. President Bill Clinton, flanked on the left by Celera Genomics Group president J. Craig Venter and on the right by National Human Genome Research Institute director Francis S. Collins, announced the completion of "the first survey of the entire human genome."
Conceptual image showing fragmented X chromosomes
How Chaos in Chromosomes Helps Drive Cancer Spread
Samuel F. Bakhoum | Mar 1, 2022 | 10+ min read
A new link between inflammation and rampant chromosomal abnormalities reveals novel strategies to treat diverse malignancies.
Tropheryma whipplei genome
Tudor Toma(t.toma@imperial.ac.uk) | Feb 23, 2003 | 1 min read
The causative agent of Whipple's disease lacks key metabolism genes.
Chromosome 21 Reveals Sparse Gene Content
Ricki Lewis | Jun 11, 2000 | 8 min read
The unveiling of the DNA sequences of human chromosomes represents a new chapter in the unfolding story of genomics, but one with roots in the half-century-old field of cytogenetics. Chromosome-level looks can reveal the specific genes behind certain traits and disorders while providing information on genome organization. The diminutive chromosome 21--the smallest of the human contingent, despite its number as next to last--is the fourth to be described. Its debut in mid-May attracted attentio
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Can Destroying Senescent Cells Treat Age-Related Disease?
Katarina Zimmer | Mar 1, 2020 | 10+ min read
A handful of clinical trials are underway to find out whether drugs that target senescent cells can slow the ravages of old age.
Gene Mapping Gives Rise To Drugs That Rebuild Tissue
Steve Bunk | Apr 26, 1998 | 8 min read
The logical outcome of gene mapping is nigh. Biotechnology companies are using genetic information to design new drugs that may go beyond merely slowing or stopping a disease process to inducing the regeneration or repair of damaged tissue. Looking past the conventional drug targets of enzymes and gene-coupled receptors, researchers are seeking out molecules in the pathways along which biochemical signals are transferred. In some cases, their work has led to compounds--now in clinical trials or
Notebook
Eugene Russo | Dec 5, 1999 | 7 min read
Contents Pivotal pump Leptin limbo Clue to obesity Biotech Web site Helping hand Mapping malaria Notebook Pictured above are pigmented bacterial colonies of Deinococcus radiodurans, the most radiation-resistant organism currently known. DEINO-MITE CLEANUP In 1956, investigators discovered a potentially invaluable cleanup tool in an unlikely place. A hardy bacterium called Deinococcus radiodurans unexpectedly thrived in samples of canned meat thought to be sterilized by gamma radiation. The b
Syphilis: Then and Now
Kristin N Harper, George J. Armelagos, and Molly K. Zuckerman | Feb 1, 2014 | 10+ min read
Researchers are zeroing in on the origin of syphilis and related diseases, which continue to plague the human population some 500 years after the first documented case.
Re-engineering Humans
The Scientist | Mar 1, 2007 | 10+ min read
We challenged experts across fields to imagine a new way to solve the problems of human aging. Our question: What if Humans were Designed to Last? By S. Jay Olshansky, Robert N. Butler, and Bruce A. Carnes Illustrations by Thom Graves When Michelangelo painted The Creation of Adam on the ceiling of the Sistine Chapel, he portrayed the Renaissance view of humanity as having been molded by the hand of its creator, a "perfect" physical spe

Run a Search

ADVERTISEMENT